Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis

Journal of Cancer Research and Clinical Oncology

Volumn 134, Issue 7, 2008, Pages 753-759

  Zimmers, Teresa A ^a   Jin, Xiaoling ^a   Gutierrez, Juan C ^a   Acosta, Cary ^a   McKillop, Iain H ^b   Pierce, Robert H ^c   Koniaris, Leonidas G ^a,d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^d UNIVERSITY OF MIAMI   (United States)

Author keywords

Growth differentiation factor 15; Hepatocellular carcinoma; hNAG 1; hPDF; hPLAB; hPTGF PL; Transforming growth factor ; Transgenic knockout

Indexed keywords

DIETHYLNITROSAMINE; GROWTH DIFFERENTIATION FACTOR 15; GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER HISTOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ALKYLATING AGENTS; ANIMALS; CARCINOMA, HEPATOCELLULAR; CYTOKINES; DIETHYLNITROSAMINE; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NEOPLASM INVASIVENESS;

EID: 43449125004     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-007-0336-4     Document Type: Article

References (41)

1. Albertoni M, Shaw PH, Nozaki M et al (2002) Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. Oncogene 21(27):4212-4219
2. Baek SJ, Kim KS, Nixon JB, Wilson LC, Eling TE (2001) Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol 59(4):901-908
3. Baek SJ, Wilson LC, Eling TE (2002) Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53. Carcinogenesis 23(3):425-434
4. Baek SJ, Kim JS, Nixon JB, DiAugustine RP, Eling TE (2004) Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1. J Biol Chem 279(8):6883-6892
5. Bottone FG Jr., Baek SJ, Nixon JB, Eling TE (2002) Diallyl disulfide (DADS) induces the antitumorigenic NSAID-activated gene (NAG-1) by a p53-dependent mechanism in human colorectal HCT 116 cells. J Nutr 132(4):773-778
6. Bottone FG Jr., Martinez JM, Alston-Mills B, Eling TE (2004) Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells. Carcinogenesis 25(3):349-357
7. Brown DA, Ward RL, Buckhaults P et al (2003) MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin Cancer Res 9(7):2642-2650
8. Buckhaults P, Rago C, St Croix B et al (2001) Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res 61(19):6996-7001
9. Esquela AF, Zimmers TA, Koniaris LG, Sitzmann JV, Lee SJ (1997) Transient down-regulation of inhibin-betaC expression following partial hepatectomy. Biochem Biophys Res Commun 235(3):553-556
10. Garrigue-Antar L, Munoz-Antonia T, Antonia SJ, Gesmonde J, Vellucci VF, Reiss M (1995) Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells. Cancer Res 55(18):3982-3987
11. Hromas R, Hufford M, Sutton J, Xu D, Li Y, Lu L (1997) PLAB, a novel placental bone morphogenetic protein. Biochim Biophys Acta 1354(1):40-44
12. Hsiao EC, Koniaris LG, Zimmers-Koniaris T, Sebald SM, Huynh TV, Lee SJ (2000) Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury. Mol Cell Biol 20(10):3742-3751
13. Huang X, Lee C (2003) From TGF-beta to cancer therapy. Curr Drug Targets 4(3):243-250
14. Jang TJ, Kang HJ, Kim JR, Yang CH (2004) Non-steroidal anti-inflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and -5 induction, which may explain sulindac sulfide induced gastric cancer cell apoptosis. Carcinogenesis 25(10):1853-1858
15. Jin X, Zimmers TA, Perez EA, Pierce RH, Zhang Z, Koniaris LG (2006) Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. Hepatology 43(3):474-484
16. Jin X, Zhang Z, Beer-Stolz D, Zimmers TA, Koniaris LG (2007) Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection. Hepatology 46(3):802-812
17. Kannan K, Amariglio N, Rechavi G, Givol D (2000) Profile of gene expression regulated by induced p53: connection to the TGF-beta family. FEBS Lett 470(1):77-82
18. Kew MC (2002) Epidemiology of hepatocellular carcinoma. Toxicology 181-182:35-38
19. Kim KS, Baek SJ, Flake GP, Loftin CD, Calvo BF, Eling TE (2002) Expression and regulation of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) in human and mouse tissue. Gastroenterology 122(5):1388-1398
20. Kim JS, Baek SJ, Sali T, Eling TE (2005) The conventional nonsteroidal anti-inflammatory drug sulindac sulfide arrests ovarian cancer cell growth via the expression of NAG-1/MIC-1/GDF-15. Mol Cancer Ther 4(3):487-493
21. Koniaris LG (2003) Induction of MIC-1/growth differentiation factor-15 following bile duct injury. J Gastrointest Surg 7(7):901-905
22. Koniaris LG, Zimmers-Koniaris T, Hsiao EC, Chavin K, Sitzmann JV, Farber JM (2001) Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. J Immunol 167(1):399-406
23. Koniaris LG, McKillop IH, Schwartz SI, Zimmers TA (2003) Liver regeneration. J Am Coll Surg 197(4):634-659
24. Lagna G, Hata A, Hemmati-Brivanlou A, Massague J (1996) Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature 383(6603):832-836
25. Lee DH, Yang Y, Lee SJ et al (2003) Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. Cancer Res 63(15):4648-4655
26. Li PX, Wong J, Ayed A et al (2000) Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J Biol Chem 275(26):20127-20135
27. Markowitz SD, Roberts AB (1996) Tumor suppressor activity of the TGF-beta pathway in human cancers. Cytokine Growth Factor Rev 7(1):93-102
28. McKillop IH, Moran DM, Jin X, Koniaris LG (2006) Molecular pathogenesis of hepatocellular carcinoma. J Surg Res 136(1):125-135
29. Monks A, Harris E, Hose C, Connelly J, Sausville EA (2003) Genotoxic profiling of MCF-7 breast cancer cell line elucidates gene expression modifications underlying toxicity of the anticancer drug 2-(4-amino-3- methylphenyl)-5-fluorobenzothiazole. Mol Pharmacol 63(3):766-772
30. Newman D, Sakaue M, Koo JS et al (2003) Differential regulation of nonsteroidal anti-inflammatory drug-activated gene in normal human tracheobronchial epithelial and lung carcinoma cells by retinoids. Mol Pharmacol 63(3):557-564
31. Paralkar VM, Vail AL, Grasser WA et al (1998) Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family. J Biol Chem 273(22):13760-13767
32. Pierce RH, Vail ME, Ralph L, Campbell JS, Fausto N (2002) Bcl-2 expression inhibits liver carcinogenesis and delays the development of proliferating foci. Am J Pathol 160(5):1555-1560
33. Siegel PM, Massague J (2003) Cytostatic and apototic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 3(11):807-821
34. Strelau J, Sullivan A, Böttner M, Lingor P, Falkenstein E, Suter-Crazzolara C, Galter D, Jaszai J, Krieglstein K, Unsicker K (2000) Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. J Neurosci 20(23):8597-8603
35. Tan M, Wang Y, Guan K, Sun Y (2000) PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway. Proc Natl Acad Sci USA 97(1):109-114
36. Vail ME, Pierce RH, Fausto N (2001) Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha. Cancer Res 61(2):594-601
37. Weber KL, Bolander ME, Rock MG, Pritchard D, Sarkar G (1998) Evidence for the upregulation of osteogenic protein-1 mRNA expression in musculoskeletal neoplasms. J Orthop Res 16(1):8-14
38. Wilson LC, Baek SJ, Call A, Eling TE (2003) Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells. Int J Cancer 105(6):747-753
39. Yokoyama-Kobayashi M, Saeki M, Sekine S, Kato S (1997) Human cDNA encoding a novel TGF-beta superfamily protein highly expressed in placenta. J Biochem (Tokyo) 122(3):622-626
40. Zimmers TA, Jin X, Hsiao EC, McGrath SA, Esquela AF, Koniaris LG (2005) Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock 23(6):543-548
41. Zimmers TA, Jin X, Hsiao EC et al (2006) Growth differentiation factor-15: induction in liver injury through p53 and tumor necrosis factor-independent mechanisms. J Surg Res 130(1):45-51